Shares of Vertex Pharmaceuticals Inc. VRTX slipped 2.92% to $485.89 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 2.24% to ...

Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our ...

03 Apr,2025 - Presented by Hastings Hastings Deering Hastings Deering is known for their expertise in customer satisfaction and providing a smooth purchasing journey for their customers. Their ...

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective increased by Bank of America from $555.00 to $567.00 in a research note issued on Monday,Benzinga reports.

Vertex’s effort to provide fertility support services to those on government insurance programs who want to take the company’s CRISPR Therapeutics-partnered gene therapy Casgevy and maintain ...

Analysts' ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) over the last quarter vary from bullish to bearish, as provided by 17 analysts. The table below summarizes their recent ratings ...

We recently published a list of Jim Cramer Looked At These 23 Stocks Recently. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against ...

Commenting on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Cramer said: “Vertex Pharma comes in second. I don’t give you that enough because they’ve got this terrific new opioid non ...

Vertex Pharmaceuticals (VRTX) closed the latest trading day at $492.69, indicating a -1.96% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily ...

Because of that strategy, consumers can find brand-name products in Ross stores ... stock in the S&P 500 trades at 23 times earnings. Vertex Pharmaceuticals: Up 18% Pharma stock Vertex ...